Financials in GBp. Standardized financial statements.
A compact view of how Oxford BioDynamics Plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £1.09M | £636,000 | £510,000 | £154,000 | £341,000 | £456,000 | £907,000 | £1.19M | £1.18M | £1.09M |
| Revenue Growth? | +72.2% | +24.7% | +231.2% | -54.8% | -25.2% | -49.7% | -23.5% | +0.3% | +8.4% | 0.0% |
| Cost of Revenue? | £7.24M | £347,000 | £244,000 | £38,000 | £898,000 | £622,000 | £468,000 | £693,000 | £407,000 | £516,000 |
| Gross Profit? | -£6.15M | £289,000 | £266,000 | £116,000 | -£557,000 | -£166,000 | £439,000 | £493,000 | £776,000 | £575,000 |
| Gross Margin? | -561.6% | +45.4% | +52.2% | +75.3% | -163.3% | -36.4% | +48.4% | +41.6% | +65.6% | +52.7% |
| Operating Expenses? | £4.51M | £13.18M | £10.43M | £8.72M | £6.96M | £4.79M | £4.16M | £3.10M | £3.29M | £2.46M |
| Operating Income? | -£10.66M | -£12.89M | -£11.03M | -£8.60M | -£7.51M | -£4.95M | -£3.72M | -£2.60M | -£4.00M | -£2.33M |
| EBITDA? | -£9.80M | -£10.27M | -£9.84M | -£6.16M | -£6.43M | -£4.42M | -£3.00M | -£2.09M | -£3.79M | -£1.91M |
| Income Before Tax | -£11.42M | -£11.96M | -£11.41M | -£7.57M | -£7.63M | -£4.91M | -£3.39M | -£2.42M | -£4.03M | -£2.07M |
| Income Tax Expense | -£269,000 | -£389,000 | -£585,000 | -£857,000 | -£947,000 | -£597,000 | -£586,000 | -£470,000 | -£228,000 | -£344,000 |
| Net Income? | -£11.15M | -£11.57M | -£10.83M | -£6.71M | -£6.68M | -£4.31M | -£2.80M | -£1.95M | -£3.80M | -£1.73M |
| EPS? | £-0.01 | £-0.05 | £-0.07 | £-0.07 | £-0.07 | £-0.05 | £-0.03 | £-0.02 | £-0.04 | £-0.02 |
| Diluted EPS? | £-0.01 | £-0.05 | £-0.07 | £-0.07 | £-0.07 | £-0.05 | £-0.03 | £-0.02 | £-0.04 | £-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality